Terminalia brownii
Terminalia brownii · Accepted scientific name
Scientific literature: Very Sparse (5 studies) · ★☆☆☆☆
Terminalia brownii is a versatile medicinal plant known for its significant therapeutic potential in treating various health conditions. Research has highlighted its potent antiplasmodial, antimalarial, and antimicrobial activities, making it a valuable resource in traditional medicine. The plant contains bioactive compounds such as triterpenoids and specifically oleanane-type triterpenoids, which contribute to its medicinal efficacy. Various parts of the plant, including the leaves, stems, roots, and seeds, are utilized through preparations like alcoholic or acetone extracts. These extracts are frequently employed to combat ailments such as malaria, diarrhea, fungal infections, and infections caused by Escherichia coli.
- Synonyms
- Myrobalanus Brownii · Terminalia Confertifolia · 5 more
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Stem
Classification
Common Names
Terminalia brownii is a distinctive plant species known by several different names across various linguistic traditions. In certain regions, it is referred to by the common name etiopianketapani. When looking toward East Asian nomenclature, the plant is identified by the Chinese name 布朗榄仁. Interestingly, it is also documented under the slightly different character variation 布朗欖仁. These diverse names highlight the wide-reaching botanical recognition of this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Terminalia brownii is a botanical species that is associated with several distinct taxonomic synonyms. Within scientific literature, this plant is also identified by the name Myrobalanus brownii. The species further encompasses various specialized forms, including Terminalia brownii var. albertensis, var. gallaensis, and var. stenocarpa. Additionally, the name Terminalia confertifolia is recognized as a synonym within its complex classification. Understanding these overlapping designations is essential for accurate identification and study of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia brownii is a distinct biological entity that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Myrtales, showcasing its evolutionary connections to related plant groups. As a member of the family Combretaceae, it shares specific structural characteristics with its kin. Ultimately, this plant is defined by its placement within the genus Terminalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia brownii is a notable plant species widely distributed across several key regions of the African continent. Within East Tropical Africa, it can be found thriving in the diverse landscapes of Kenya, Tanzania, and Uganda. Its presence also extends into the Northeast Tropical Africa region, showcasing significant ecological adaptability. Specifically, the species has been documented growing within the territories of both Chad and Djibouti. This broad geographic range highlights the importance of the species across various African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia brownii is a self-supporting plant that adopts a distinct tree growth form. This species typically reaches a maximum height of approximately 12.19 meters. However, under certain conditions, it can grow even taller, reaching a peak of up to 15 meters. Its sturdy structure allows it to stand firmly within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia brownii has demonstrated significant therapeutic potential through its diverse biological activities. Research indicates that this medicinal plant possesses potent antiplasmodial properties, effectively targeting both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. Furthermore, studies conducted on mice have confirmed its promising antimalarial activity, particularly through the use of aqueous and hydromethanolic bark extracts. Beyond its effects on malaria parasites, the plant also exhibits notable antimicrobial activity against various species of fungi and bacteria. These combined findings suggest that T. brownii is a valuable candidate for the development of new, cost-effective pharmacotherapies.
Compounds
Terminalia brownii is an African medicinal plant that has undergone extensive phytochemical investigation. Through the analysis of its ethyl acetate-soluble stem bark extract, researchers identified a diverse range of bioactive compounds. Notably, the plant contains various triterpenoids, including seven previously known varieties. The study also led to the successful isolation of a unique, new oleanane-type triterpenoid. This specific compound was identified using advanced spectroscopic methods such as 1D- and 2D NMR.
Conditions
Terminalia brownii demonstrates significant antimicrobial properties by effectively treating Escherichia coli and Staphylococcus aureus. The plant's extracts are also utilized in traditional medicine to treat fungal infections, such as Candida, and to manage diarrhea. Furthermore, studies have identified Terminalia brownii as a potent agent for treating malaria due to its strong antiplasmodial activity. These various therapeutic applications highlight the plant's versatility in addressing both bacterial and parasitic ailments.
Preparations
Terminalia brownii is prepared as various extracts to utilize its medicinal properties against diverse pathogens. Specifically, the plant is prepared as acetone extracts of the leaves and acetone extracts of the roots to demonstrate antifungal activity. Research also shows that Terminalia brownii is prepared as alcoholic extracts, which have exhibited significant inhibition of the SARS-CoV-2 main protease. Additionally, the plant is prepared as aqueous extracts that have been used by herbalists to treat bacterial ailments. These diverse preparation methods, including the use of different solvents, allow for the isolation of bioactive compounds from the plant's various parts.
Parts used
Terminalia brownii is a versatile African medicinal plant that possesses several biologically active components used in traditional healing. Research indicates that the plant's leaves contain lectins with significant analgesic and antiulcer properties, as well as potent antidiarrheal activity. The seeds are also a source of valuable lectins that contribute to the plant's diverse therapeutic profile. Furthermore, the stem and bark have been studied for their antimicrobial effects and their ability to yield important triterpenoids. Finally, the roots of the plant demonstrate significant antibacterial and antifungal activities, reinforcing its widespread use in treating various infections.